Comparison of the provision of champedon trunk shell capsule extract and artesunate on placental histopathologic classification in pregnant mice (Mus musculus) malaria model
Downloads
Objectives: To compare the effect of chemphedon trunk shell capsule extract with artesunate on placental histopathologic classification in pregnant mice malaria's models.
Materials and Methods: This study was a randomized experi-mental laboratory study in BALBc strains mice with controls. A total of 30 pregnant mice were divided into 3 groups. On day 10 each group was infected with P. berghei. Furthermore, on day 11 each group was subjected to thin blood smear examination and subsequent infection when administered antimalarial positive. Group P1 received Chemphedon trunk shell extract 100 mg/kg BW/day per sonde two times per day for 5 days. Group P2 received 36.4 mg artesunate/kg BW/day for 3 days followed by CMC Na per sonde for 2 days, and group P3 received placebo (CMC Na) for 5 days. On day 16 the mice were dissected on 16 days of pregnancy and the placenta was taken and preparations were made to observe histopathological classification of the placenta according to Rogerson. Grouping was performed accor-ding to placental histopathological classification by Rogerson.
Results: Groups receiving cemphedon trunk shell capsule extract, artesunate and placebo revealed p=0.004 (p<0.05), showing that there were two groups with significant difference. To determine which group had significant difference, the test was followed by Mann-Whitney post-hoc test. The results showed chempedon trunk shell capsule group and placebo obtained p=0.007 (p<0.05), indicating significance. Artesunate and placebo groups revealed p=0.003 (p<0.05), also indicating significance. The test results of chemphedon trunk shell capsule extract and artesunate groups showed p=0.475 (p<0.05), indicating no significant differences.
Conclusion: Placental histopathologic classification on pregnant mice malaria's model that received antimalarial chemphedon trunk shell capsule extract of 100 mg/kg BW is better than place-bo and equivalent to artesunate of 36.4mg/kg BW.
WHO. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Indonesia. Summary Report 2010. [cited 2013 May 10]. Available from: http://apps.who.int/hpvcentre/Sta-tistics/ dynamic/ico/country _pdf/IDN.pdf. 2010.
Zaravinos A, Mammas IN, Sourvinos G, Spandi-dos DA. Molecular detection methods of Human Papillomavirus. The International Journal of Biological Markers. 2009;24(4):215-22.
Gutiérrez-Xicoténcatl L, Plett-Torres T, Madrid-González CL, Madrid-Marina V. Molecular diagno-sis of human papillomavirus in the development of cervical cancer. Cuernavaca Jan. 2009;51(3).
Ellenson LH and Pirog EC. The female genital tract. In: Robbins and Cotran Pathologic Basis of Disease. 8th Eds. Philadelphia: Saunders Elsevier; 2010. p. 1017-24.
Meijer CJ, Snijders PJ, Castle PE. Clinical utility of HPV genotyping. Gynecologic Oncology. 2006; 103:12-7.
Youens KE, Hosler GA, Washington PJ et al. Clinical experience with the Cervista HPV HR Assay Correlation of Cytology and HPV Status from 56,501 specimens. The Journal of Molecular Diagnostics. 2011;13(2):160-6.
Andrijono. Vaksinasi HPV merupakan pencegahan primer kanker serviks. Majalah Kedokteran Indonesia. 2007;57(5):153-8.
Djauzi S and Rengganis I. Imunisasi Human Pap-pilomavirus (HPV). In: Andrijono dan Indriatmi W, editors. Infeksi Human Pappilomavirus. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2013. p. 189-98.
Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer [internet] [cited 2013]. Available from: http://dx. doi.org/10.1016/S0140-6736(13) 60022-7. 2013.
Kumar V, Abbas A, Fausto N. Neoplasia. In: Rob-bins and Contrans Pathologic Basis of Diseas-es. 8th Eds. Philadelphia: Saunders Elsevier; 2010.
Berek JS, editor. Berek & Novak's Ginecology. 14th eds. New York: Lippincot Williams and Wilkins; 2007. p. 1404-50.
Montag A and Kumar V. The female genital system and breast. In: Robbin Basic Pathology. 8th Eds. Philadelphia: Saunders Elsevier; 2010. p 716-20.
Smith JS, Lindsay L, Hoots B, et al. Human papilloma-virus type distribution in invasive cervical cancer and high grade cervical lesions. Int J Cancer. 2007;121(3):621-32.
Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, et al. Human Papillomavirus prevalence, geno-type distribution and pattern of infection in Thai women. Asian Pacific J Cancer Prev. 2011; 12:853-6.
Sasagawa T, Basha W, Yamazaki H, Inoue M. High-risk and multiple human papilloma-virus infections associated with cervical abnor-malities in Japanese women. Cancer Epidemiol Biomarkers Prev. 2001;10:45-52.
Bao YP, Li N, Smith JS, Qiao YL, ACCPAB mem-bers. Human pappilomavirus type distribution in women from Asia: a Meta-analysis. International. Journal of Gynecological Cancer. 2007:1-9.
Wiser MF. Biochemistry of Plasmodium Review. Tulane University [internet] [updated 2001]. Available from: http:www.tulane.edu/wiser/ malaria/cmb.html
Rogerson SJ, Mwapasa V, Meshnick SR. Malaria in pregnancy: Linking immunity and pathogenesis to prevention. American Journal Tropical Medicine and Hygiene. 2007;77(Suppl 6): 14-22
Hafid AF, Widyawruyanti A, Ariantari NP, et al. The active marker compound identification of artocarpus champeden spreng. stembark extract, morachalchone a as antimalarial. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4(5).
Cook GC and Zumla A. Manson's Tropical Disease. 21th edn. London: Saunder Elseiver Science; 2003
Tushar KV, George S, Remashree, Balachandran I. Coscinium fenestratum, critical endangered and highly trated medicinal species. Journal of Plant Sciences. 2008;3(2): 133-45.
Fidock DA, Rosenthal PJ, Croft et al. 2004. Antimalarial drug discovery : Efficacy models for compound screening. Review. Nature. 2004;3(6): 509-20.
Dewi RM, Jekti RP, Sulaksono E. 1997. Pengaruh pasase terhadap gejala klinis pada mencit strain Swiss derived yang diinfeksi Plasmodium berghei. Cermin Dunia Kedokteran. 1997;06:34-6.
Syarif A. Farmakologi dan terapi. 4th edn. Bagian Farmakologi. Fakultas Kedokteran Universitas Indonesia. Jakarta: Gaya Baru; 2007.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.